VKTX

Viking Therapeutics, Inc.

Biotechnology · Biotechnology

$310.88 sample

+0.54 (+0.17%) 1D

Market cap

$508.3B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-13

Alerts

8

Price$310.88 +5.99% 3M daily closessample

310.88278.24

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13SEC8-K filed: material event
Oct 08INSInsider buy: General Counsel
Oct 05INSInsider buy: Chief Executive Officer
Sep 29INSInsider buy: Chief Executive Officer
Sep 22INSInsider sell: Director
Sep 14INSInsider sell: Chief Financial Officer
Sep 09INSInsider sell: Chief Executive Officer
Aug 31SECForm 144 filed

Sign up to see the real VKTX record →

Company facts

SEC EDGAR registration

Name: Viking Therapeutics, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -23sample, -100 to +100
Reporting currency: USD

Who is positioning in VKTX

sample

Insiders: 18 insider transactions over 90 days, net selling, $471.2M
Congress: 2 members traded over 90 days
Institutions · 13F: 42 funds hold $9.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$21.8B +16.9% y/y

Q4 2024Q3 2026

Inventory$13.1B +16.1% y/y

Q4 2024Q3 2026

Accounts receivable$10.2B +14.6% y/y

Q4 2024Q3 2026

Total debt$26.4B +12.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $342.0B -10.0% 3M
Sample peer B: $415.7B +5.2% 3M
Sample peer C: $137.0B -3.8% 3M
Sample peer D: $490.6B +5.0% 3M
Sample peer E: $282.4B -1.8% 3M